Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chubb
Cantor Fitzgerald
US Army
McKinsey
Accenture
Johnson and Johnson
QuintilesIMS
Medtronic

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,039,474

« Back to Dashboard

Summary for Patent: 8,039,474
Title:2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists
Abstract: The invention relates to novel tetrahydro-1H-carbazole derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and methods of treatment comprising administration of said compounds to patients.
Inventor(s): Fecher; Anja (Basel, CH), Fretz; Heinz (Riehen, CH), Riederer; Markus (Liestal, CH)
Assignee: Actelion Pharmaceutical Ltd. (Allschwil, CH)
Application Number:11/722,095
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 8,039,474

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,039,474

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
PCT/EP2004/014719Dec 27, 2004
PCT Information
PCT FiledDecember 22, 2005PCT Application Number:PCT/IB2005/054380
PCT Publication Date:July 06, 2006PCT Publication Number: WO2006/070325

International Family Members for US Patent 8,039,474

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 052549 ➤ Try a Free Trial
Austria 518834 ➤ Try a Free Trial
Australia 2005320964 ➤ Try a Free Trial
Brazil PI0519280 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Colorcon
Chubb
Federal Trade Commission
Baxter
Moodys
Daiichi Sankyo
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.